| scholarly article | Q13442814 |
| P2093 | author name string | Raheel Qamar | |
| Maleeha Azam | |||
| Nadia Khalida Waheed | |||
| Syeda Hafiza Benish Ali | |||
| Aisha Azam | |||
| Irfan Muslim | |||
| Muhammad Shakil Khan | |||
| Sundas Ejaz Maqsood | |||
| Khadija Tariq | |||
| Saira Bano Malik | |||
| P2860 | cites work | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes | Q24290189 |
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| Retinopathy in diabetes | Q28166601 | ||
| The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism | Q28216175 | ||
| mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer | Q29617271 | ||
| Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response | Q33343728 | ||
| Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. | Q33591693 | ||
| PPARgamma, the ultimate thrifty gene | Q33711175 | ||
| The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes | Q33899154 | ||
| PPAR gamma and human metabolic disease | Q34416432 | ||
| Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction | Q34509923 | ||
| Is the Ala12 variant of the PPARG gene an "unthrifty allele"? | Q35448715 | ||
| Microvascular complications of impaired glucose tolerance. | Q35591509 | ||
| Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies | Q35976372 | ||
| Effect of novel water soluble curcumin derivative on experimental type- 1 diabetes mellitus (short term study) | Q36499074 | ||
| Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy. | Q37029158 | ||
| A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity | Q38331543 | ||
| Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. | Q41275648 | ||
| Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin | Q42492673 | ||
| Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis | Q42806100 | ||
| Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity | Q43566173 | ||
| Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians | Q43763530 | ||
| Reduced lipolysis as possible cause for greater weight gain in subjects with the Pro12Ala polymorphism in PPARgamma2? | Q43886617 | ||
| Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study | Q44081051 | ||
| Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes | Q44509605 | ||
| The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes | Q44666346 | ||
| A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 | ||
| Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis | Q45050542 | ||
| Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes | Q45050575 | ||
| Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation | Q46671380 | ||
| Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes | Q47330796 | ||
| Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. | Q51499010 | ||
| Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes | Q57639011 | ||
| Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes | Q74671754 | ||
| The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects | Q77924533 | ||
| Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model | Q79143850 | ||
| An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits | Q80159483 | ||
| Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma | Q81554853 | ||
| P921 | main subject | diabetic retinopathy | Q631361 |
| proliferative diabetic retinopathy | Q18967481 | ||
| P304 | page(s) | 710-717 | |
| P577 | publication date | 2013-03-21 | |
| P1433 | published in | Molecular Vision | Q6895981 |
| P1476 | title | Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy | |
| P478 | volume | 19 |
| Q39089813 | A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression |
| Q90446393 | Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers |
| Q28073127 | Candidate gene studies of diabetic retinopathy in human |
| Q35110729 | GRK5 intronic (CA)n polymorphisms associated with type 2 diabetes in Chinese Hainan Island |
| Q36493240 | Interaction between peroxisome proliferator- activated receptor gamma polymorphism and overweight on diabetic retinopathy in a Chinese case-control study |
| Q98164364 | PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis |
| Q35867091 | Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy |
| Q26773225 | Update on genetics and diabetic retinopathy |
| Q36374238 | ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. |
Search more.